JP2023529828A5 - - Google Patents

Info

Publication number
JP2023529828A5
JP2023529828A5 JP2022574179A JP2022574179A JP2023529828A5 JP 2023529828 A5 JP2023529828 A5 JP 2023529828A5 JP 2022574179 A JP2022574179 A JP 2022574179A JP 2022574179 A JP2022574179 A JP 2022574179A JP 2023529828 A5 JP2023529828 A5 JP 2023529828A5
Authority
JP
Japan
Prior art keywords
compound
treprostinyl
fdkp
formula
protected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022574179A
Other languages
English (en)
Japanese (ja)
Other versions
JP7608480B2 (ja
JP2023529828A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/036335 external-priority patent/WO2021252446A1/en
Publication of JP2023529828A publication Critical patent/JP2023529828A/ja
Publication of JP2023529828A5 publication Critical patent/JP2023529828A5/ja
Priority to JP2024221661A priority Critical patent/JP2025041731A/ja
Application granted granted Critical
Publication of JP7608480B2 publication Critical patent/JP7608480B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022574179A 2020-06-09 2021-06-08 トレプロスチニルのフマリルジケトピペリジンプロドラッグ Active JP7608480B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024221661A JP2025041731A (ja) 2020-06-09 2024-12-18 トレプロスチニルのフマリルジケトピペリジンプロドラッグ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063036561P 2020-06-09 2020-06-09
US63/036,561 2020-06-09
PCT/US2021/036335 WO2021252446A1 (en) 2020-06-09 2021-06-08 Fumaryl diketopiperidine prodrugs of treprostinil

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024221661A Division JP2025041731A (ja) 2020-06-09 2024-12-18 トレプロスチニルのフマリルジケトピペリジンプロドラッグ

Publications (3)

Publication Number Publication Date
JP2023529828A JP2023529828A (ja) 2023-07-12
JP2023529828A5 true JP2023529828A5 (enExample) 2024-06-17
JP7608480B2 JP7608480B2 (ja) 2025-01-06

Family

ID=76731024

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022574179A Active JP7608480B2 (ja) 2020-06-09 2021-06-08 トレプロスチニルのフマリルジケトピペリジンプロドラッグ
JP2024221661A Pending JP2025041731A (ja) 2020-06-09 2024-12-18 トレプロスチニルのフマリルジケトピペリジンプロドラッグ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024221661A Pending JP2025041731A (ja) 2020-06-09 2024-12-18 トレプロスチニルのフマリルジケトピペリジンプロドラッグ

Country Status (9)

Country Link
US (3) US11793780B2 (enExample)
EP (1) EP4161909A1 (enExample)
JP (2) JP7608480B2 (enExample)
KR (2) KR20250057075A (enExample)
CN (1) CN116113415A (enExample)
AU (2) AU2021289336B2 (enExample)
CA (1) CA3180230A1 (enExample)
IL (1) IL298591A (enExample)
WO (1) WO2021252446A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022229367A1 (en) 2021-03-03 2023-09-14 United Therapeutics Corporation A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp)
US20230263807A1 (en) 2022-02-08 2023-08-24 United Therapeutics Corporation Treprostinil iloprost combination therapy

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2485614A (en) 1946-08-29 1949-10-25 Chicago Bridge & Iron Co Stabilizing and guide apparatus for lifter roofs
US3037116A (en) 1957-07-26 1962-05-29 Weber Georges Apparatus for irradiating liquids
US3035516A (en) 1958-08-18 1962-05-22 Lee Brothers Company Stencil device
US3646509A (en) 1969-08-08 1972-02-29 Texas Instruments Inc Method for field stacking seismic data and system using write after read bulk data storage
US4306075A (en) 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4547016A (en) 1984-08-13 1985-10-15 Eeco Incorporated Quick release mounting
GB8814438D0 (en) 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
IT1231076B (it) 1989-09-28 1991-11-12 Pirelli Cavi Spa Procedimento per la realizzazione di gruppo di connessione separabile per fibre ottiche riunite a nastro e gruppo di connessione con esso realizzato.
GB9011588D0 (en) 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
KR100638684B1 (ko) 1997-11-14 2006-10-27 유나이티드 세러퓨틱스 코오포레이션 말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도
US6521212B1 (en) 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
EP1164846A1 (en) 1999-03-31 2002-01-02 United Therapeutics Corporation Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6803386B2 (en) 2002-01-16 2004-10-12 United Therapeutics Corporation Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
US6756117B1 (en) 2002-12-20 2004-06-29 The United States Of America As Represented By The United States Department Of Energy Photonic polymer-blend structures and method for making
ES2670872T3 (es) 2003-05-22 2018-06-01 United Therapeutics Corporation Polimorfo de una sal de dietanolamina de treprostinil
US8765813B2 (en) 2003-12-16 2014-07-01 United Therapeutics Corporation Use of treprostinil to treat and prevent ischemic lesions
JP4906514B2 (ja) 2003-12-16 2012-03-28 ユナイテッド セラピューティクス コーポレイション 腎臓機能改善のためのトレプロスチニルの用途
US20090124697A1 (en) 2003-12-16 2009-05-14 United Therapeutics Corporation Inhalation formulations of treprostinil
CA2562614C (en) 2004-04-12 2013-09-17 United Therapeutics, Inc. Use of treprostinil to treat neuropathic diabetic foot ulcers
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
JP5797376B2 (ja) 2006-05-15 2015-10-21 ユナイテッド セラピューティクス コーポレーション 定量吸入器を用いたトレプロスチニル投与
US20090036465A1 (en) 2006-10-18 2009-02-05 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
US20080280986A1 (en) 2007-02-09 2008-11-13 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
EP2711024B1 (en) 2007-09-07 2019-03-06 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
WO2009078965A1 (en) 2007-12-17 2009-06-25 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin
KR20110010753A (ko) 2008-05-08 2011-02-07 유나이티드 세러퓨틱스 코오포레이션 트레프로스티닐 일수화물
EP2427054A4 (en) 2009-05-07 2014-01-15 United Therapeutics Corp SOLID COMPOSITIONS BASED ON PROSTACYCLINE ANALOGS
US20120184622A1 (en) 2009-08-07 2012-07-19 Scipharm Sarl Composition for the treatment of cystic fibrosis
EP2482840A4 (en) * 2009-08-07 2013-06-26 Mannkind Corp VAL (8) GLP-1 COMPOSITION AND METHOD FOR THE TREATMENT OF REAGENTS AND / OR IRRITATION SYNDROME
JP5681276B2 (ja) 2010-03-15 2015-03-04 ユナイテッド セラピューティクス コーポレイション 肺高血圧症のための治療
US8481782B2 (en) 2010-06-03 2013-07-09 United Therapeutics Corporation Treprostinil production
CA2710726C (en) 2010-07-22 2016-02-23 Alphora Research Inc. Synthesis of treprostinil and intermediates useful therein
CA2710725C (en) 2010-07-22 2017-08-01 Alphora Research Inc. Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation
CA2726599C (en) 2010-12-30 2017-07-25 Alphora Research Inc. Process for treprostinil salt preparation
KR101454571B1 (ko) 2011-03-02 2014-10-23 유나이티드 세러퓨틱스 코오포레이션 트레프로스티닐 생산을 위한 중간체 합성
EP2741781A1 (en) * 2011-08-12 2014-06-18 Ascendis Pharma A/S Carrier-linked treprostinil prodrugs
WO2013040068A2 (en) 2011-09-12 2013-03-21 Irix Pharmaceuticals, Inc. Process for preparing synthetic prostacyclins
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
US9387214B2 (en) 2012-01-13 2016-07-12 United Therapeutics Corporation Method of identifying therapies for pulmonary hypertension
LT2674413T (lt) 2012-06-15 2017-09-25 Scipharm Sąrl Treprostinilo ir jo darinių gavimo būdas
JP6357481B2 (ja) 2012-11-30 2018-07-11 インスメッド， インコーポレイテッド プロスタサイクリン化合物およびプロスタサイクリン化合物を使用する方法
MX369094B (es) 2012-12-07 2019-10-29 Cayman Chemical Co Inc Metodos para sintetizar un analogo de prostaciclina.
ES2927844T3 (es) 2013-01-11 2022-11-11 Corsair Pharma Inc Profármacos de treprostinil
CA3125504C (en) 2013-03-14 2023-10-24 United Therapeutics Corporation Solid forms of treprostinil
KR20150128903A (ko) 2013-03-15 2015-11-18 유나이티드 세러퓨틱스 코오포레이션 트레프로스티닐의 염
WO2014160638A1 (en) * 2013-03-25 2014-10-02 United Therapeutics Corporation Process of making prostacyclin compounds with linker thiol and pegylated forms
EP2991639A4 (en) 2013-04-30 2016-11-30 United Therapeutics Corp PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE
SI3060041T1 (sl) 2013-10-25 2021-04-30 Insmed Incorporated Spojine prostaciklina
JO3624B1 (ar) 2014-05-08 2020-08-27 Lilly Co Eli تركيبات إنسولين سريعة المفعول
JP6037085B2 (ja) 2014-05-14 2016-11-30 富士電機株式会社 半導体装置および半導体装置の製造方法
ES2908142T3 (es) 2014-06-13 2022-04-27 United Therapeutics Corp Formulaciones de treprostinil
US20160045470A1 (en) 2014-08-12 2016-02-18 Dr. Reddy's Laboratories Limited Amorphous solid dispersion of treprostinil diethanolamine
WO2016038532A1 (en) 2014-09-09 2016-03-17 Mylan Laboratories Limited Amorphous treprostinil diethanolamine
HU231184B1 (hu) 2014-10-08 2021-07-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Treprostinil-nátrium-monohidrát és eljárás ennek előállítására
US9593061B2 (en) 2014-10-20 2017-03-14 United Therapeutics Corporation Synthesis of intermediates for producing prostacyclin derivatives
EP3904326A1 (en) 2014-11-18 2021-11-03 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
TWI540121B (zh) 2014-12-01 2016-07-01 臺灣永光化學工業股份有限公司 曲前列環素二乙醇胺之合成方法及新穎中間體
US10837038B2 (en) 2014-12-23 2020-11-17 National Technology & Engineering Solutions Of Sandia, Llc Adjusting the pH of a pretreatment solution using carbon dioxide useful for integrating saccharification and fermentation
AU2017211410B2 (en) * 2016-01-29 2022-10-13 Mannkind Corporation Dry powder inhaler
CA3038276A1 (en) 2016-09-26 2018-03-29 United Therapeutics Corporation Treprostinil prodrugs
EP3498283A1 (en) 2017-12-14 2019-06-19 Ipsol AG Glycosidic derivatives of treprostinil
JP2021527058A (ja) 2018-06-07 2021-10-11 マンカインド コーポレイション 吸入のための組成物および方法

Similar Documents

Publication Publication Date Title
CA2908244C (en) Process of making prostacyclin compounds with linker thiol and pegylated forms
CN1582272A (zh) 制备5－(3－氰基苯基)－3－甲酰基苯甲酸化合物的方法
CN1060778C (zh) 头孢菌素衍生物
CN1137892C (zh) N-9取代的鸟嘌呤化合物的制备
CN1247573C (zh) 制备芳基乙酰基氨基噻唑的方法
US6340756B1 (en) Process for preparing a 2-(2-amino-1, 6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
CN1029965C (zh) 具有氨基噻唑(亚氨基氧基乙酸)乙酸侧链的β-内酰胺的制备方法
MXPA02001396A (es) Proceso para la preparacion de un analogo de carbonato de metilo del carbono 4, del paclitaxel.
CN1036712C (zh) 抗病毒剂[1R-(1α，2β，3α)]-2-氨基-9-[2，3-双(羟甲基)环丁基]-1，9-二氢-6H-嘌呤-6-酮的制备方法
US8853453B2 (en) Processes for reducing impurities in lacosamide
WO2011104540A1 (en) One step process for the preparation of capecitabine
CN1835918A (zh) 外消旋2－{[2－(4－羟基苯基)乙基]硫基}－3－[4－(2－{4－[(甲磺酰基)氧基]苯氧基}乙基)苯基]－丙酸的制备方法
CN1064683C (zh) 制备嘌呤衍生物的方法
US20230374060A1 (en) Novel method for preparing inotodiol
JP2023541840A5 (enExample)
CN1257166C (zh) 制备具有抗组胺活性的三环化合物的方法
US20030149284A1 (en) Method of synthesizing a paclitaxel derivative
CN101044130A (zh) 一种制备缩水甘油衍生物的方法
JP4163113B2 (ja) 新規化合物及びその製造方法
JP4829418B2 (ja) 光学活性なハロヒドリン誘導体およびその使用方法
EP3445745B1 (en) Process for the preparation of bimatoprost
CN1646532A (zh) 2,6－二卤代嘌呤的制备方法
CN1740155A (zh) 选择性合成氟伐他汀的中间体及其制备方法和用途
US20090163513A1 (en) Process for ziprasidone using novel intermediates
CN1687032A (zh) 氟伐他汀合成中间体及其制备方法和用途